# EDGAR Filing Document

**Accession Number:** 0002030763
**File Stem:** 0000000000-25-008372
**Filing Date:** 2025-8
**Character Count:** 3649
**Document Hash:** f3d629e6f962a85c24b0eae9c6b19cfd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-008372.hdr.sgml**: 20260304

**ACCESSION NUMBER**: 0000000000-25-008372

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250808

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Wellgistics Health, Inc.
- **CENTRAL INDEX KEY:** 0002030763
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 933264234
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 377-07892

**BUSINESS ADDRESS:**
- **STREET 1:** 3000 BAYPORT DRIVE SUITE 950
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33607
- **BUSINESS PHONE:** 1-843-302-1785

**MAIL ADDRESS:**
- **STREET 1:** 3000 BAYPORT DRIVE SUITE 950
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33607

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Danam Health, Inc
- **DATE OF NAME CHANGE:** 20240717
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001641172-25-004615

## Text-Extract

```

                                                            August 8, 2025

Brian Norton
Chief Executive Officer
Wellgistics Health, Inc.
3000 Bayport Drive, Suite 950
Tampa, FL 33607

       Re: Wellgistics Health, Inc.
           Registration Statement on Form S-1
           Filed July 24, 2025
           File No. 333-288932
Dear Brian Norton:

       We have conducted a limited review of your registration statement and
have the
following comment(s).

        Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe a comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments.

Registration Statement on Form S-1
Use of Proceeds, page 11

1.     We note the disclosure surrounding your planned XRP Treasury Strategy
and its
       execution in "the near future." If you intend on using the proceeds of
this offering to
       purchase XRP to further your XRP Treasury Strategy, please disclose as
much in this
       section. Refer to Instruction 5 to Item 504 of Regulation S-K.
2.     We note the disclosure surrounding your planned acquisition of Peek
Healthcare
       Technologies, Inc. If you intend on using the proceeds of this offering
to finance the
       acquisition of Peek Healthcare Technologies, Inc., please disclose as
much in this
       section. Refer to Instruction 6 to Item 504 of Regulation S-K.
 August 8, 2025
Page 2

        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence
of action by the staff.

       Refer to Rules 460 and 461 regarding requests for acceleration. Please
allow adequate
time for us to review any amendment prior to the requested effective date of
the registration
statement.

      Please contact Nicholas Nalbantian at 202-551-7470 or Dietrich King at
202-551-
8071 with any questions.

                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of Trade &
Services
cc:   Kate Bechen

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._